webinar register page

Topic

'Meet the Author' webinar "Lymph node colonization induces tumor-immune tolerance to promote distant metastasis" with Prof. Edgar G. Engleman and Dr. Nathan E. Reticker-Flynn

Description

The European Association for Cancer Research invites you to join this free virtual event, exclusively available to EACR members, hosted by Prof. Edgar G. Engleman and Dr. Nathan E. Reticker-Flynn, alongside Dr Alexandra Boitor (EACR Scientific Officer)

Format:
A 60-minute webinar with Prof. Edgar G. Engleman and Dr. Nathan E. Reticker-Flynn with plenty of time for participants to submit typed questions. Participants will not be visible but will have the opportunity to use their microphones to ask questions verbally if they choose to.

Programme:
This 30-minute presentation is by Prof. Edgar G. Engleman and Dr. Nathan E. Reticker-Flynn from Stanford University. Edgar and Nathan study the biology of immune cells and their roles in the pathogenesis of cancers. Their recent work, published in Cell and featured in our Highlights in cancer research article, combines systems approaches, genomic tools, and mouse models and seeks to identify the underpinnings of tumour-specific tolerance induction during lymph node metastasis. This webinar aims to discuss in great detail their most recent paper "Lymph node colonization induces tumor-immune tolerance to promote distant metastasis” and we are looking forward to hearing any ‘behind the scene’ stories from their research.

Q&A: Participants will be able to type questions throughout the talk, and you will be able to ‘upvote’ questions you’d like to be answered.

Time Zone: CET – Central European Time. UTC+1
Calendar: Don't forget to add this to your calendar! Options are provided once your registration is accepted and you receive your registration details
Participants: Places are only open to EACR members

Have a question? Check our virtual event FAQs: https://www.eacr.org/virtualeventfaqs

Time

Nov 30, 2022 05:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: European Association for Cancer Research (EACR).

All fields are required

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Nov 30, 2022 17:00 Amsterdam, Berlin, Rome, Stockholm, Vienna Topic: 'Meet the Author' webinar "Lymph node colonization induces tumor-immune tolerance to promote distant metastasis" with Prof. Edgar G. Engleman and Dr. Nathan E. Reticker-Flynn Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_8_tqf7ckTZ-5qzWq64YTWA After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Nathan Reticker-Flynn (Instructor, Pathology @Stanford University) Nathan is a Biomedical Engineer and tumor immunologist working at the interfaces of cancer metastasis, tumor evolution, adaptive immunity, and immuno-oncology. His work employs mouse models and systems biology and genetic engineering to investigate interactions between tumors and the immune system during cancer metastasis. He performed his PhD work in Biomedical Engineering with Dr. Sangeeta Bhatia at MIT where he studied glycobiology and ECM interactions during cancer metastasis and his postdoctoral studies with Dr. Edgar Engleman at Stanford where he studied systemic immune responses during metastatic progression and in the context of immunotherapy. Edgar Engleman (Professor of Pathology and of Medicine (Immunology and Rheumatology) @Stanford University) We study the biology of immune cells and their roles in the pathogenesis of cancers and other life-threatening diseases. By applying new and more precise analytical tools for assessing this system in mice and humans, we have been successful at identifying disease-promoting immune abnormalities. By targeting the cells responsible for or affected by these abnormalities, we have succeeded in reversing the abnormalities and ameliorating the diseases they cause. We make extensive use of mouse models for in depth mechanistic studies, but we also use human tissues to confirm the clinical relevance of our findings. Edgar is also a Member of Bio-X, Maternal & Child Health Research Institute (MCHRI), Stanford Cancer Institute and Wu Tsai Neurosciences Institute. He is the Co-Director, Tumor Immunology and Immunotherapy, Stanford Cancer Institute (2008 - Present), Medical Director, Stanford Blood Center (1980 - Present) and Member, Stanford Diabetes Research Center, Stanford (2018 - Present)

Time Zone:

webinar register page

Share via Email

Switch Time Zone

Upcoming Meetings